Hugel Inc., a global total medical aesthetics company, recently held a Medical Aesthetics International Exchange in Asia to discuss the latest treatment techniques and industry trends.
According to Hugel on the 25th, the event was attended by leading medical professionals from Asia, along with Vice President Ji Seung-wook and employees from its subsidiary and domestic sales division. Representatives from Hugel’s partner, Sihuan Pharmaceutical, also participated.
During the session, participants exchanged views on topics including 2026 aesthetic trends, next-generation anti-aging strategies, and clinic operation models.
In particular, directors from the Dayview Network — including Kim Young-soo, Moon Jung-hoon and Jung Yu-jin — attended and shared practical insights from clinical settings. Kim Jung-hwan of Dr. Evers Myeongdong presented a lecture and live demonstration on combination procedures using botulinum toxin and hyaluronic acid (HA) fillers.
Through the event, Asian medical professionals were able to directly observe the precision techniques of K-aesthetics and real clinical cases, while gaining practical know-how on the diverse applications of Hugel’s “Letybo.”
At the same time, Asian medical professionals gained a deeper understanding of the characteristics and demand of patients visiting Asia, broadening mutual understanding.
Ji Seung-wook, vice president of Hugel, said, “Since the early stages of entering the Asian market, Hugel has strengthened the Letybo brand and its credibility through three pillars — authenticity, academic excellence, and premium positioning,” adding, “We will continue to create opportunities for exchange between Asian medical professionals and expand cooperation through the sharing of theory and clinical experience.”